Welcome!

.NET Authors: Yeshim Deniz, Carmen Gonzalez, Greg O'Connor, Pat Romanski, Elizabeth White

News Feed Item

Express Scripts Reports Fourth Quarter and Full Year Results

Provides Initial 2013 Earnings Guidance

ST. LOUIS, Feb. 18, 2013 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2012 fourth quarter and full year net income attributable to Express Scripts shareholders from continuing operations of $515.9 million and $1,340.5 million, or $0.62 and $1.79 per diluted share, respectively. Adjusted earnings per share attributable to Express Scripts from continuing operations, as detailed in Table 4 were $1.05 and $3.74 per diluted share for the fourth quarter and full year, respectively.

"2012 was a monumental year for Express Scripts as we closed the acquisition of Medco and made significant progress integrating the two companies," stated George Paz, chairman and chief executive officer. "Our financial performance in 2012 was strong, and as we look to the future, we are well positioned to capitalize on the complementary strengths of the combined organization, which enhance our ability to improve health outcomes, lower health care costs and continue to deliver long-term growth."

Fourth Quarter 2012 Review (Results from continuing operations on an adjusted basis where indicated. See Tables 2 and 3)

All key metrics compared to 2011 were affected by the inclusion of Medco results beginning in the second quarter of 2012. Gross profit margin and EBITDA per adjusted claim increases over last year are mainly attributed to improved operating performance, increased generic utilization and realization of synergies.

  • Adjusted claims of 410.8 million, up 111%
  • Gross profit of $2.3 billion, up 160%
  • EBITDA of $1.6 billion, up 131%
  • EBITDA per adjusted claim of $4.01, up 10%
  • Cash flow from operations of $2.6 billion, compared to $0.5 billion in the fourth quarter of 2011

Full Year 2012 Review (Results from continuing operations on an adjusted basis where indicated. See Tables 2 and 3)

  • Adjusted claims of 1,395.7 million, up 86%
  • Gross profit of $7.5 billion, up 123%
  • EBITDA of $5.4 billion, up 103%
  • EBITDA per adjusted claim of $3.87, up 9%
  • Cash flow from operations of $4.8 billion, including merger-related costs, up from $2.2 billion in 2011

Due to the Federal Holiday on February 18, 2013, the Company expects to file its Annual Report on Form 10-K for the year ended December 31, 2012 with the Securities and Exchange Commission ("SEC") on Tuesday, February 19, 2013. However, in connection with this earnings release, the contents of the Form 10-K substantially in the form expected to be filed on Tuesday, February 19, 2013, are expected to be made available to the public on the "Investor Information" section of the Company's website at approximately 4:00 pm Eastern Time (3:00 p.m. Central Time) on Monday, February 18, 2013 at www.express-scripts.com/corporate. The Form 10-K, as filed with the SEC, will replace that document on the Company's website as soon as practicable following its filing with the SEC.

2013 Guidance

The Company expects to achieve adjusted earnings per diluted share from continuing operations for 2013 in the range of $4.20 to $4.30, or 12% to 15% growth over 2012. Adjusted earnings per share for 2013 exclude items as detailed in Table 6.

  • Total adjusted claims are expected to grow 5% to 7% from 1,395.7 million adjusted claims reported in 2012
  • Selling, general and administrative expense is expected to decline 8% to 10% from $2,365.9 million reported on an adjusted basis in 2012
  • EBITDA per adjusted claim is expected to grow 15% to 18% from $3.87 reported on an adjusted basis in 2012
  • Effective tax rate is expected to be approximately 39%
  • Diluted shares outstanding is expected to be in a range of 825 million to 835 million

About Express Scripts

Express Scripts (NASDAQ: ESRX) manages more than a billion prescriptions each year for tens of millions of patients. On behalf of our clients – employers, health plans, unions and government health programs – we make the use of prescription drugs safer and more affordable. Express Scripts uniquely combines three capabilities – behavioral sciences, clinical specialization and actionable data – to create Health Decision Science(SM), our innovative approach to help individuals make the best drug choices, pharmacy choices and health choices. Better decisions mean healthier outcomes.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

For more information, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter.

SAFE HARBOR STATEMENT

This press release contains forward-looking statements, including, but not limited to, statements related to the Company's plans, objectives, expectations (financial and otherwise) or intentions. Actual results may differ significantly from those projected or suggested in any forward-looking statements. Factors that may impact these forward-looking statements can be found in the Management's Discussion and Analysis of Financial Condition and Results of Operations in the Company's Form 10-K filed with the SEC on or about February 19, 2013. A copy of this form can be found at the Investor Relations section of Express Scripts' web site at http://www.express-scripts.com/corporate.

We do not undertake any obligation to release publicly any revisions to such forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.


EXPRESS SCRIPTS HOLDING COMPANY

Unaudited Consolidated Statement of Operations










Three Months Ended

December 31,


Year Ended

December 31,

(in millions, except per share data)

2012


2011


2012


2011









Revenues(*)

$ 27,410.7


$ 12,101.4


$ 93,858.1


$ 46,128.3

Cost of revenues(*)

25,107.8


11,256.9


86,527.9


42,918.4

   Gross profit

2,302.9


844.5


7,330.2


3,209.9

Selling, general and administrative

1,398.4


268.0


4,545.7


895.5

Operating income

904.5


576.5


2,784.5


2,314.4

Other (expense) income:








   Equity income from joint venture

5.5


-


14.9


-

   Interest income

4.6


4.6


10.6


12.4

   Interest expense and other

(157.4)


(115.4)


(619.0)


(299.7)


(147.3)


(110.8)


(593.5)


(287.3)

Income before income taxes

757.2


465.7


2,191.0


2,027.1

Provision for income taxes

234.4


173.7


833.3


748.6

Net income from continuing operations

522.8


292.0


1,357.7


1,278.5

Net loss from discontinued operations, net of tax

(11.8)


-


(27.6)


-

Net income

511.0


292.0


1,330.1


1,278.5

Less: Net income attributable to non-controlling interest

6.9


1.6


17.2


2.7

Net income attributable to Express Scripts

$ 504.1


$ 290.4


$ 1,312.9


$ 1,275.8









Weighted average number of common shares outstanding during the period:















   Basic

817.3


485.3


731.3


500.9

   Diluted

832.4


489.0


747.3


505.0









Basic earnings (loss) per share








   Continuing operations attributable to Express Scripts

$ 0.63


$ 0.60


$ 1.83


$ 2.55

   Discontinued operations attributable to Express Scripts

(0.01)


-


(0.04)


-

   Net earnings attributable to Express Scripts

0.62


0.60


1.80


2.55









Diluted earnings (loss) per share








   Continuing operations attributable to Express Scripts

$ 0.62


$ 0.59


$ 1.79


$ 2.53

   Discontinued operations attributable to Express Scripts

(0.01)


-


(0.04)


-

   Net earnings attributable to Express Scripts

0.61


0.59


1.76


2.53









Amounts attributable to Express Scripts shareholders:








   Income from continuing operations, net of tax

$ 515.9


$ 290.4


$ 1,340.5


$ 1,275.8

   Discontinued operations, net of tax

(11.8)


-


(27.6)


-

   Net income attributable to Express Scripts shareholders

$ 504.1


$ 290.4


$ 1,312.9


$ 1,275.8









(*) Includes retail pharmacy co-payments of $3,304.0 million and $1,412.6 million for the three months ended December 31, 2012 and 2011, respectively and $11,668.6 million and $5,786.6 million for the year ended December 31, 2012 and 2011, respectively.

EXPRESS SCRIPTS HOLDING COMPANY

Unaudited Consolidated Balance Sheet






December 31,


December 31,

(in millions)

2012


2011

Assets




Current assets:




Cash and cash equivalents

$ 2,793.9


$ 5,620.1

Restricted cash and investments

19.6


17.8

Receivables, net

5,480.6


1,915.7

Inventories

1,661.9


374.4

Deferred taxes

408.5


45.8

Prepaid expenses and other current assets

194.4


84.2

Current assets of discontinued operations

198.0


-

Total current assets

10,756.9


8,058.0

Property and equipment, net

1,634.3


416.2

Goodwill

29,359.8


5,485.7

Other intangible assets, net

16,037.9


1,620.9

Other assets

56.6


26.2

Noncurrent assets of discontinued operations

265.7


-

Total assets

$ 58,111.2


$ 15,607.0





Liabilities and stockholders' equity




Current liabilities:




Claims and rebates payable

$ 7,440.0


$ 2,874.1

Accounts payable

2,909.1


928.1

Accrued expenses

1,630.0


656.0

Current maturities of long-term debt

934.9


999.9

Current liabilities of discontinued operations

143.4


-

Total current liabilities

13,057.4


5,458.1

Long-term debt

14,980.1


7,076.4

Deferred taxes

5,948.8


546.5

Other liabilities

692.9


50.7

Noncurrent liabilities of discontinued operations

36.3


-

Total liabilities

34,715.5


13,131.7





Stockholders' equity:




Preferred stock, 15.0 shares authorized, $0.01 par value per share;




and no shares issued and outstanding

-


-

Common stock, 2,985.0 shares authorized, $0.01 par value per share;




shares issued: 818.1 and 690.7, respectively;




shares outstanding: 818.1 and 484.6, respectively

8.2


6.9

Additional paid-in capital

21,289.7


2,438.2

Accumulated other comprehensive income

18.9


17.0

Retained earnings

2,068.2


6,645.6


23,385.0


9,107.7





Common stock in treasury at cost, zero and 206.1 shares, respectively

-


(6,634.0)

Total Express Scripts stockholders' equity

23,385.0


2,473.7

Non-controlling interest

10.7


1.6

Total stockholders' equity

23,395.7


2,475.3

Total liabilities and stockholders' equity

$ 58,111.2


$ 15,607.0

EXPRESS SCRIPTS HOLDING COMPANY

Unaudited Consolidated Statement of Cash Flows


Year Ended

December 31,

(in millions)

2012


2011





Cash flows from operating activities:




Net income

$ 1,330.1


$ 1,278.5

Net loss from discontinued operations, net of tax

27.6


-

  Net income from continuing operations

1,357.7


1,278.5

Adjustments to reconcile net income to net cash provided by operating activities:




Depreciation and amortization

1,872.6


253.4

Deferred income taxes

(390.4)


137.8

Employee stock-based compensation expense

410.0


48.8

Bad debt expense

158.8


11.6

Deferred financing fees

43.6


81.0

Other, net

(118.5)


4.5

Changes in operating assets and liabilities, net of effects of acquisition:




Receivables

325.2


(206.1)

Inventories

(515.8)


8.0

Other current and noncurrent assets

303.2


119.2

Claims and rebates payable

82.8


207.5

Accounts payable

982.2


271.4

Other current and noncurrent liabilities

240.8


(22.5)

Net cash provided by operating activities - continuing operations

4,752.2


2,193.1

Net cash provided by operating activities - discontinued operations

29.4


-

Net cash flows provided by operating activities

4,781.6


2,193.1





Cash flows from investing activities:




Acquisitions, net of cash acquired

(10,326.4)


-

Purchases of property and equipment

(160.2)


(144.4)

Purchase of short-term investments

(2.8)


(25.0)

Proceeds from sale of short-term investments

4.6


45.0

Proceeds from sale of business

61.5


-

Other

(5.8)


0.5

Net cash used in investing activities - continuing operations

(10,429.1)


(123.9)

Acquisitions, cash acquired - discontinued operations

42.8


-

Net cash used in investing activities - discontinued operations

(5.4)


-

Net cash used in investing activities

(10,391.7)


(123.9)





Cash flows from financing activities:




Proceeds from long-term debt, net of discounts

7,458.9


5,580.3

Repayment of long-term debt

(3,868.5)


(0.1)

Repayment of revolving credit line, net

(1,000.0)


-

Proceeds from accounts receivable financing facility

600.0


-

Repayment of accounts receivable financing facility

(600.0)


-

Excess tax benefit relating to employee stock-based compensation

45.3


28.3

Net proceeds from employee stock plans

326.0


32.2

Deferred financing fees

(103.2)


(91.6)

Treasury stock acquired

-


(2,515.7)

Distributions paid to non-controlling interest

(8.1)


(1.1)

Other

-


(2.9)

Net cash provided by financing activities - continuing operations

2,850.4


3,029.4

Net cash used in financing activities - discontinued operations

(26.8)


-

Net cash provided by financing activities

2,823.6


3,029.4





Effect of foreign currency translation adjustment

2.0


(2.2)





Less: cash attributable to discontinued operations

(41.7)


-





Net (decrease) increase in cash and cash equivalents

(2,826.2)


5,096.4

Cash and cash equivalents at beginning of year

5,620.1


523.7

Cash and cash equivalents at end of year

$ 2,793.9


$ 5,620.1

Table 1

Express Scripts Holding Company Unaudited Consolidated Selected Information

(in millions)










Three Months Ended

December 31,


Year Ended

December 31,


2012


2011


2012


2011

Claims Volume








Continuing operations:








Network

299.2


156.4


1,020.7


600.4

Home delivery and specialty(1)

38.3


13.6


129.1


53.4

   Total claims

337.5


170.0


1,149.8


653.8









Total adjusted claims - continuing operations(2)

410.8


194.9


1,395.7


751.5









Discontinued operations:








Home delivery and specialty(1)

1.2


-


4.9


-









Total adjusted claims - discontinued operations(2)

3.6


-


14.7


-









Depreciation and Amortization (D&A):








Revenue amortization(3)

$ 28.5


$ 28.5


$ 114.0


$ 114.0

Cost of revenues depreciation

32.0


12.3


105.3


43.5

Selling, general and administrative depreciation

58.4


14.9


178.9


55.2

Selling, general and administrative amortization

483.1


10.2


1,474.4


40.7

   Total D&A - continuing operations

$ 602.0


$ 65.9


$ 1,872.6


$ 253.4









Generic Fill Rate








Network

80.6%


75.8%


79.4%


75.3%

Home delivery

73.7%


64.7%


71.5%


63.0%

Overall

79.8%


74.8%


78.5%


74.2%









Note: See Appendix for Footnotes and Additional Notes.

    

Table 2

Calculation of Express Scripts Holding Company Adjusted Gross Profit and SG&A - Continuing Operations

(in millions)










Three Months Ended

December 31,


Year Ended

December 31,


2012


2011


2012


2011

Gross profit, as reported

$ 2,302.9


$ 844.5


$ 7,330.2


$ 3,209.9

Amortization of legacy Express Scripts intangible assets (3)

28.5


28.5


114.0


114.0

Non-recurring transaction and integration costs (4)

16.0


-


49.7


-

Accrual related to client contractual dispute (5)

-


30.0


-


30.0

Adjusted gross profit

$ 2,347.4


$ 903.0


$ 7,493.9


$ 3,353.9









Selling, general and administrative, as reported

$ 1,398.4


$ 268.0


$ 4,545.7


$ 895.5

Amortization of legacy Express Scripts intangible assets (3)

10.2


10.2


40.7


40.7

Amortization of Medco-related intangible assets (6)

472.9


-


1,433.7


-

Non-recurring transaction and integration costs (4)

130.8


42.2


705.4


62.5

Adjusted selling, general and administrative

$ 784.5


$ 215.6


$ 2,365.9


$ 792.3









Note: See Appendix for Footnotes and Additional Notes.

    



The Company is providing adjusted gross profit and adjusted selling, general and administrative expenses, in each case, excluding the impact of non-recurring charges and amortization of intangible assets (both of which are non-GAAP financial measures) in order to compare the underlying financial performance to prior periods.

    

Table 3

Express Scripts Holding Company EBITDA Reconciliation

(in millions, except per claim data)

The following is a reconciliation of net income from continuing operations attributable to Express Scripts to EBITDA from continuing operations attributable to Express Scripts. The Company believes net income is the most directly comparable measure calculated under U.S. GAAP.


Three Months Ended

December 31,


Year Ended

December 31,


2012


2011


2012


2011

Net income from continuing operations, attributable to Express Scripts, as reported

$ 515.9


$ 290.4


$ 1,340.5


$ 1,275.8

  Provision for income taxes

234.4


173.7


833.3


748.6

  Depreciation and amortization

602.0


65.9


1,872.6


253.4

  Interest expense, net

152.8


110.8


608.4


287.3

  Equity income from joint venture

(5.5)


-


(14.9)


-

EBITDA from continuing operations, attributable to Express Scripts, as reported

1,499.6


640.8


4,639.9


2,565.1

Non-recurring transaction and integration costs (4)

146.8


42.2


755.1


62.5

Accrual related to client contractual dispute (5)

-


30.0


-


30.0

Adjusted EBITDA from continuing operations, attributable to Express Scripts

$ 1,646.4


$ 713.0


$ 5,395.0


$ 2,657.6









Total adjusted claims - continuing operations

410.8


194.9


1,395.7


751.5









Adjusted EBITDA per adjusted claim

$ 4.01


$ 3.66


$ 3.87


$ 3.54









Note: See Appendix for Footnotes and Additional Notes.





    



The Company is providing adjusted EBITDA excluding the impact of non-recurring charges in order to compare the underlying financial performance to prior periods.


EBITDA is earnings before other income (expense), interest, taxes, depreciation and amortization, or alternatively calculated as operating income plus depreciation and amortization. EBITDA is presented because it is a widely accepted indicator of a company's ability to service indebtedness and is frequently used to evaluate a company's performance. EBITDA, however, should not be considered as an alternative to net income, as a measure of operating performance, as an alternative to cash flow, as a measure of liquidity or as a substitute for any other measure computed in accordance with accounting principles generally accepted in the United States. In addition, our definition and calculation of EBITDA may not be comparable to that used by other companies.


Adjusted EBITDA per adjusted claim is a supplemental measurement used by analysts and investors to help evaluate overall operating performance. We have calculated adjusted EBITDA excluding certain charges recorded each year, as these charges are not considered an indicator of ongoing company performance. Adjusted EBITDA per adjusted claim is calculated by dividing adjusted EBITDA by the adjusted claim volume for the period. This measure is used as an indicator of EBITDA performance on a per-unit basis. Adjusted EBITDA, and as a result, adjusted EBITDA per adjusted claim, are affected by the changes in claim volumes between retail and mail-order, the relative representation of brand-name, generic and specialty pharmacy drugs, as well as the level of efficiency in the business.

    

Table 4

Calculation of Express Scripts Holding Company Adjusted EPS










Three Months Ended

December 31,


Year Ended

December 31,


2012


2011


2012


2011




(per diluted share)



EPS from continuing operations attributable to Express Scripts, as reported

$ 0.62


$ 0.59


$ 1.79


$ 2.53









Non-recurring/transaction-related items:








Transaction and integration costs (4)

0.11


0.06


0.61


0.08

Medco acquisition pre-close financing costs (7)

-


0.08


0.07


0.13

Discrete tax items (8)

(0.06)


-


(0.01)


-

Accrual related to client contractual dispute (5)

-


0.04


-


0.04









Amortization of:








Legacy Express Scripts intangible assets(3)

0.03


0.05


0.12


0.19

Medco-related intangible assets(6)

0.35


-


1.16


-









EPS from continuing operations, adjusted

$ 1.05


$ 0.82


$ 3.74


$ 2.97









EPS from discontinued operations attributable to Express Scripts, as reported

$ (0.01)


$ -


$ (0.04)


$ -









Non-recurring/transaction-related items:








Transaction and integration costs (9)

-


-


0.01


-









Amortization of:








Medco-related intangible assets(9)

-


-


0.02


-









EPS from discontinued operations, adjusted

$ (0.01)


$ -


$ (0.01)


$ -









Total EPS attributable to Express Scripts, adjusted

$ 1.04


$ 0.82


$ 3.73


$ 2.97









Note: See Appendix for Footnotes and Additional Notes.









The Company is providing EPS and EPS excluding the impact of non-recurring / transaction-related items and amortization of intangible assets (which is a non-GAAP financial measure) in order to compare the underlying financial performance to prior periods.










Table 5

Calculation of Express Scripts Holding Company Adjusted Effective Income Tax Rate

(in millions)


Year Ended

December 31, 2012




Pre-Tax


Provision for Income Taxes


Adjusted Effective Income Tax Rate



Income from continuing operations, as reported

2,191.0


833.3





Income from discontinued operations, as reported

(15.4)


12.2






2,175.6


845.5





Non-controlling interest

(17.2)


-





Total operations attributable to Express Scripts

2,158.4


845.5





Discrete tax items(8)

-


8.2





Total operations attributable to Express Scripts

2,158.4


853.7


39.6%











Note: See Appendix for Footnotes and Additional Notes.









The Company is providing adjusted effective income tax rate excluding the impact of discrete tax items (which is a non-GAAP financial measure) in order to compare the underlying financial performance to prior periods.

         


Table 6

2013 Guidance Information


Estimated

Year Ended

December 31, 2013


(per diluted share)





Adjusted EPS from continuing operations guidance

$ 4.20

to

$ 4.30





GAAP items not included in guidance:








Amortization of legacy Express Scripts intangible assets

$0.11



Amortization of Medco-related intangible assets (10)

$1.38





Transaction, integration and other non-recurring costs(11)

To be determined





Note: See Appendix for Footnotes and Additional Notes.


The full-year impact of Medco-related transaction and integration costs have yet to be determined. Accordingly, the Company is unable to include these charges in the list of GAAP items not included in guidance for 2013 revised adjusted EPS from continuing operations or to provide a reconciliation to the corresponding GAAP measure.

Appendix

Footnotes


(1) Includes home delivery, specialty and other including: (a) drugs distributed through patient assistance programs (b) drugs we distribute to other PBMs' clients under limited distribution contracts with pharmaceutical manufacturers and (c) FreedomFP claims.


(2) Total adjusted claims reflect home delivery claims multiplied by 3, as home delivery claims typically cover a time period 3 times longer than retail claims.


(3) Amortization of legacy Express Scripts intangible assets include amounts in both revenues and selling, general and administrative expense. Revenue amortization is related to the customer contract with WellPoint which consummated upon closing of the NextRx acquisition in 2009. Under U.S. GAAP standards, amortization of intangibles that arise in connection with consideration given to a customer by a vendor is characterized as a reduction of revenues. Intangible amortization of $28.5 million ($17.1 million and $17.9 million net of tax in 2012 and 2011, respectively) is included as a reduction to revenue for the three months ended December 31, 2012 and 2011. Intangible amortization of $114.0 million ($68.8 million and $71.9 million net of tax in 2012 and 2011, respectively) is included as a reduction to revenue for the year ended December 31, 2012 and 2011.

 

In addition, intangible amortization of $10.2 million ($6.1 million and $6.4 million net of tax in 2012 and 2011, respectively) is included in selling, general and administrative expense in the three months ended December 31, 2012 and 2011. Intangible amortization of $40.7 million ($24.5 million and $25.7 million net of tax in 2012 and 2011, respectively) is included in selling, general and administrative expense in the year ended December 31, 2012 and 2011.


(4) Non-recurring transaction and integration costs include those directly related to the acquisition of Medco Health Solutions, Inc. ("Medco").

 

Costs of $16.0 million ($10.4 million net of tax) and $49.7 million ($30.0 million net of tax) for the three months and year ended December 31, 2012, respectively, primarily composed of integration-related activities, are included in cost of revenues.

 

Costs of $131.3 million ($85.0 million net of tax) and $42.2 million ($26.4 million net of tax) primarily composed of severance costs, including stock compensation, are included in selling, general and administrative expense in the three months ended December 31, 2012 and 2011, respectively. Costs of $697.2 million ($420.7 million net of tax) and $62.5 million ($39.4 million net of tax) are included in selling, general and administrative expense in the years ended December 31, 2012 and 2011, respectively.

 

The Company recorded a net benefit of $0.5 million ($0.4 million net of tax) and net charges of $8.2 million ($4.9 million net of tax) within selling, general and administrative expenses for the three months and year ended December 31, 2012, respectively, in conjunction with the strategic decision to exit various businesses.


(5) In December 2011, the Company recorded an accrual of $30 million ($18.9 million net of tax) as an offset to revenues for the year ended December 31, 2011 related to a client contractual dispute.


(6) Amortization of intangible assets related to the acquisition of Medco of $472.9 million ($289.6 million net of tax) and $1,433.7 million ($865.2 million net of tax) for the three months and year ended December 31, 2012, respectively is included in selling, general and administrative expense.


(7) Financing costs include fees related to the amortization of remaining bridge loan fees, commitment fees related to the new credit agreement and interest and fees on the senior notes secured in conjunction with the acquisition of Medco. Costs of $63.1 million ($39.5 million net of tax) is included in interest expense in the three months ended December 31, 2011. Costs of $85.2 million ($52.3 million net of tax) and $105.0 million ($66.2 million net of tax) is included in interest expense for the years ended December 31, 2012 and 2011, respectively.


(8) Provision for income taxes includes discrete tax benefits of $51.7 million and $8.2 million for the quarter and year ended December 31, 2012, respectively. These items primarily relate to adjustments to prior year income tax return filings partially offset by a reversal of the deferred tax asset previously established for transaction-related costs that became nondeductible upon the consummation of the Merger.


(9) Net income from discontinued operations, net of tax includes $8.1 million ($5.0 million net of tax) and $25.1 million ($15.2 million net of tax) of amortization of intangible assets related to the acquisition of Medco for the three months and year ended December 31, 2012, respectively.

 

In addition, net income from discontinued operations, net of tax for the three months and year ended December 31, 2012, respectively includes a benefit of $3.7 million ($2.3 million net of tax) and charges of $7.8 million ($4.8 million net of charges) in conjunction with the strategic decision to exit various businesses.


(10) Adjusted EPS will exclude amortization of intangible assets. The current estimate of full year amortization based on the preliminary purchase price allocation for the Medco transaction. The preliminary purchase price allocation may be subject to further refinement and may result in significant changes.


(11) Adjusted EPS will exclude Medco-related transaction, integration and other non-recurring costs, including premium on early retirement of debt. The full-year impact of these costs have yet to be determined.

Appendix

Additional Notes


The Company now recognizes net income attributable to non-controlling interest which represents the share of net income allocated to members in consolidated affiliates. This share of net income was previously included within selling, general and administrative costs on the consolidated statement of operations. This classification impacted all quarters in 2012 and the third and fourth quarters of 2011 and did not impact net income attributable to Express Scripts shareholders.

 

During the fourth quarter of 2012, the Company determined that portions of the business within the Other Business Operations segment were not core to future operations and committed to a plan to dispose of these businesses. Consequently, results for the year ended December 31, 2012 have been adjusted for the discontinued operations of these businesses. This adjustment for discontinued operations impacts the second, third and fourth quarters of 2012.


Consult the Investor Information section of the Express Scripts website for the 2012 Express Scripts Recast worksheet, a document that recasts historical information reflecting these changes as www.express-scripts.com/corporate

SOURCE Express Scripts Holding Company

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

@ThingsExpo Stories
The Internet of Things (IoT) is making everything it touches smarter – smart devices, smart cars and smart cities. And lucky us, we’re just beginning to reap the benefits as we work toward a networked society. However, this technology-driven innovation is impacting more than just individuals. The IoT has an environmental impact as well, which brings us to the theme of this month’s #IoTuesday Twitter chat. The ability to remove inefficiencies through connected objects is driving change throughout every sector, including waste management. BigBelly Solar, located just outside of Boston, is trans...
SYS-CON Events announced today that Matrix.org has been named “Silver Sponsor” of Internet of @ThingsExpo, which will take place on November 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA. Matrix is an ambitious new open standard for open, distributed, real-time communication over IP. It defines a new approach for interoperable Instant Messaging and VoIP based on pragmatic HTTP APIs and WebRTC, and provides open source reference implementations to showcase and bootstrap the new standard. Our focus is on simplicity, security, and supporting the fullest feature set.
Predicted by Gartner to add $1.9 trillion to the global economy by 2020, the Internet of Everything (IoE) is based on the idea that devices, systems and services will connect in simple, transparent ways, enabling seamless interactions among devices across brands and sectors. As this vision unfolds, it is clear that no single company can accomplish the level of interoperability required to support the horizontal aspects of the IoE. The AllSeen Alliance, announced in December 2013, was formed with the goal to advance IoE adoption and innovation in the connected home, healthcare, education, aut...
SYS-CON Events announced today that Red Hat, the world's leading provider of open source solutions, will exhibit at Internet of @ThingsExpo, which will take place on November 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA. Red Hat is the world's leading provider of open source software solutions, using a community-powered approach to reliable and high-performing cloud, Linux, middleware, storage and virtualization technologies. Red Hat also offers award-winning support, training, and consulting services. As the connective hub in a global network of enterprises, partners, a...

SUNNYVALE, Calif., Oct. 20, 2014 /PRNewswire/ -- Spansion Inc. (NYSE: CODE), a global leader in embedded systems, today added 96 new products to the Spansion® FM4 Family of flexible microcontrollers (MCUs). Based on the ARM® Cortex®-M4F core, the new MCUs boast a 200 MHz operating frequency and support a diverse set of on-chip peripherals for enhanced human machine interfaces (HMIs) and machine-to-machine (M2M) communications. The rich set of periphera...

The only place to be June 9-11 is Cloud Expo & @ThingsExpo 2015 East at the Javits Center in New York City. Join us there as delegates from all over the world come to listen to and engage with speakers & sponsors from the leading Cloud Computing, IoT & Big Data companies. Cloud Expo & @ThingsExpo are the leading events covering the booming market of Cloud Computing, IoT & Big Data for the enterprise. Speakers from all over the world will be hand-picked for their ability to explore the economic strategies that utility/cloud computing provides. Whether public, private, or in a hybrid form, clo...
Software AG helps organizations transform into Digital Enterprises, so they can differentiate from competitors and better engage customers, partners and employees. Using the Software AG Suite, companies can close the gap between business and IT to create digital systems of differentiation that drive front-line agility. We offer four on-ramps to the Digital Enterprise: alignment through collaborative process analysis; transformation through portfolio management; agility through process automation and integration; and visibility through intelligent business operations and big data.
The Transparent Cloud-computing Consortium (abbreviation: T-Cloud Consortium) will conduct research activities into changes in the computing model as a result of collaboration between "device" and "cloud" and the creation of new value and markets through organic data processing High speed and high quality networks, and dramatic improvements in computer processing capabilities, have greatly changed the nature of applications and made the storing and processing of data on the network commonplace.
Be Among the First 100 to Attend & Receive a Smart Beacon. The Physical Web is an open web project within the Chrome team at Google. Scott Jenson leads a team that is working to leverage the scalability and openness of the web to talk to smart devices. The Physical Web uses bluetooth low energy beacons to broadcast an URL wirelessly using an open protocol. Nearby devices can find all URLs in the room, rank them and let the user pick one from a list. Each device is, in effect, a gateway to a web page. This unlocks entirely new use cases so devices can offer tiny bits of information or simple i...
Things are being built upon cloud foundations to transform organizations. This CEO Power Panel at 15th Cloud Expo, moderated by Roger Strukhoff, Cloud Expo and @ThingsExpo conference chair, will address the big issues involving these technologies and, more important, the results they will achieve. How important are public, private, and hybrid cloud to the enterprise? How does one define Big Data? And how is the IoT tying all this together?
The Internet of Things (IoT) is going to require a new way of thinking and of developing software for speed, security and innovation. This requires IT leaders to balance business as usual while anticipating for the next market and technology trends. Cloud provides the right IT asset portfolio to help today’s IT leaders manage the old and prepare for the new. Today the cloud conversation is evolving from private and public to hybrid. This session will provide use cases and insights to reinforce the value of the network in helping organizations to maximize their company’s cloud experience.
TechCrunch reported that "Berlin-based relayr, maker of the WunderBar, an Internet of Things (IoT) hardware dev kit which resembles a chunky chocolate bar, has closed a $2.3 million seed round, from unnamed U.S. and Switzerland-based investors. The startup had previously raised a €250,000 friend and family round, and had been on track to close a €500,000 seed earlier this year — but received a higher funding offer from a different set of investors, which is the $2.3M round it’s reporting."
The Industrial Internet revolution is now underway, enabled by connected machines and billions of devices that communicate and collaborate. The massive amounts of Big Data requiring real-time analysis is flooding legacy IT systems and giving way to cloud environments that can handle the unpredictable workloads. Yet many barriers remain until we can fully realize the opportunities and benefits from the convergence of machines and devices with Big Data and the cloud, including interoperability, data security and privacy.
All major researchers estimate there will be tens of billions devices - computers, smartphones, tablets, and sensors - connected to the Internet by 2020. This number will continue to grow at a rapid pace for the next several decades. Over the summer Gartner released its much anticipated annual Hype Cycle report and the big news is that Internet of Things has now replaced Big Data as the most hyped technology. Indeed, we're hearing more and more about this fascinating new technological paradigm. Every other IT news item seems to be about IoT and its implications on the future of digital busines...
Cultural, regulatory, environmental, political and economic (CREPE) conditions over the past decade are creating cross-industry solution spaces that require processes and technologies from both the Internet of Things (IoT), and Data Management and Analytics (DMA). These solution spaces are evolving into Sensor Analytics Ecosystems (SAE) that represent significant new opportunities for organizations of all types. Public Utilities throughout the world, providing electricity, natural gas and water, are pursuing SmartGrid initiatives that represent one of the more mature examples of SAE. We have s...
The Internet of Things needs an entirely new security model, or does it? Can we save some old and tested controls for the latest emerging and different technology environments? In his session at Internet of @ThingsExpo, Davi Ottenheimer, EMC Senior Director of Trust, will review hands-on lessons with IoT devices and reveal privacy options and a new risk balance you might not expect.
IoT is still a vague buzzword for many people. In his session at Internet of @ThingsExpo, Mike Kavis, Vice President & Principal Cloud Architect at Cloud Technology Partners, will discuss the business value of IoT that goes far beyond the general public's perception that IoT is all about wearables and home consumer services. The presentation will also discuss how IoT is perceived by investors and how venture capitalist access this space. Other topics to discuss are barriers to success, what is new, what is old, and what the future may hold.
Swiss innovators dizmo Inc. launches its ground-breaking software, which turns any digital surface into an immersive platform. The dizmo platform seamlessly connects digital and physical objects in the home and at the workplace. Dizmo breaks down traditional boundaries between device, operating systems, apps and software, transforming the way users work, play and live. It supports orchestration and collaboration in an unparalleled way enabling any data to instantaneously be accessed on any surface, anywhere and made interactive. Dizmo brings fantasies as seen in Sci-fi movies such as Iro...
There’s Big Data, then there’s really Big Data from the Internet of Things. IoT is evolving to include many data possibilities like new types of event, log and network data. The volumes are enormous, generating tens of billions of logs per day, which raise data challenges. Early IoT deployments are relying heavily on both the cloud and managed service providers to navigate these challenges. In her session at 6th Big Data Expo®, Hannah Smalltree, Director at Treasure Data, to discuss how IoT, Big Data and deployments are processing massive data volumes from wearables, utilities and other mach...
This Internet of Nouns trend is still in the early stages and many of our already connected gadgets do provide human benefits over the typical infotainment. Internet of Things or IoT. You know, where everyday objects have software, chips, and sensors to capture data and report back. Household items like refrigerators, toilets and thermostats along with clothing, cars and soon, the entire home will be connected. Many of these devices provide actionable data - or just fun entertainment - so people can make decisions about whatever is being monitored. It can also help save lives.